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Abstract
Retinitis Pigmentosa is a disease which can cause blindness and affects around 2.5 million
people worldwide. It is a disorder that has a multitude of ways of being inherited, such as
autosomal dominant, autosomal recessive as well as X-linked and mitochondrial linked disorder.
While some versions of RP may be syndromic (20%-30%), a majority of cases are in fact nonsyndromic. The majority of non-syndromic cases inherited via autosomal dominant RP having
RHO gene mutations, and X-linked means of inheritance having majority of patients with RPGR
gene mutations. Ushers Syndrome, a syndromic version of retinitis pigmentosa and autosomal
recessive RP having a majority of patients suffering from USH2A gene mutation, is associated
with both vision loss as well as hearing impairment as the disease progresses and is found in 2040% of cases whom have developed the disease via autosomal recessive inheritance (10-20% of
cases worldwide). The symptoms of the two diseases are not dependent upon one another; with
cases of patients either having complete loss of both visual and auditory function, loss of strictly
visual function with no hearing loss, or loss of hearing with no loss of visual function. RP is
insidious in nature – in that it begins to slowly degenerate the vision of an individual over a
period of time, and thus presents with varying symptoms as the disease progresses. Due to the
varying genetic mutations that RP can be linked to, researchers do not know of an exact
pathology that can be attributed to all cases found in individuals, which makes the disease all the
more difficult to cure. Many researchers have looked to counteract the onset/progression of RP
via a plethora of methods such as gene therapy, cell therapy, antioxidant medication and even
retinal prostheses based on the many theories of how the genetic mutations lead to a multitude of
stressed within the patients eye (metabolic, trophic and oxidative stress).
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Retinitis Pigmentosa Overview
a. Anatomy of the Eye/Overview of the Cells of the Retina
Retinitis Pigmentosa (RP) largely occurs in photoreceptors of the retina, as well as the
retinal pigment epithelium cells – although to a lesser degree (1). The retina lies in the back side
of an eye, which is the entrance of the visual system and receives light inputs through the cornea,
lens, and vitreous. (Figure 1).
The retina is composed of ten distinct layers with several cell types, including pigment
epithelium, rod and cone photoreceptors, bipolar cells and ganglion cells. Photoreceptors are the
main cell types that are affected in patients with RP. Photoreceptors sense the light input, which
convert photon inputs into electrical signals. The electrical signals are passed on to bipolar cells,
then to ganglion cells, which are output neurons of the retina. Ganglion cells send visual signals
to the thalamus (lateral geniculate nucleus) by long axons, and then signals are conveyed to the
visual cortex. This process is initiated by the two main functioning photoreceptors; rods and
cones, of which light sensitivity is high and low, respectively. Rods (Figure 2) are found in
abundance in the periphery of the retina (1), and allow us to see in dim light conditions. Cones
are found primarily in the center portion of the retina – namely the fovea – and allow individuals
to perceive high definition images as well as color (Figure 2) (2).
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(Figure 2) NIH

The photoreceptors consist of four compartments: the nucleus, a short axon, an outer
segment (OS) and an inner segment (IS) – with the IS located posterior to the bipolar neurons,
and the OS anterior to the pigment epithelium. The IS is the soma (cell body) portion of the
photoreceptors. It contains most, if not all, membrane bound organelles utilized by both
photoreceptors – namely the mitochondria, ribosomes and nucleus (3). The synaptic terminals of
the photoreceptors are also present at the IS. The axon terminals of cones are known as pedicles,
while the rod axon terminals are known as spherule. Pedicles are large, conical, flat-end-feet that
lie side by side on at the outer plexiform layer. Rod spherules are small, round enlargements of
the axon, or can even extend from the cell body, and lie packed between or above cone pedicles
(3). Both rod spherules and cone pedicles synapse at second-order neurons (bipolar cells and
horizontal cells) of the retina, and both contain a dense structure known as a synaptic ribbon
which indicates the usage of postsynaptic invaginated processes in order to send to signals via
glutamate. The ribbon structure of both the rod and cone synaptic terminals (Figures 3 and 4) is
the synaptic release site where synaptic vesicles packed with glutamate dock and release
glutamate onto horizontal cells (orange) and bipolar cells (red, and blue) dendrites (3). The OS
are specialized sensory cilia, analogous to other structures containing nonmotile cilia (4). The
dysfunction of the OS – normally caused by a mutation in cilia genes (ciliopathies) – can lead to
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a decrease in the phototransduction pathway, since the function of the OS is light detection using
tightly packed membranous discs which contain visual pigments, as well as phototransduction
proteins (i.e. rhodopsin) (4). The IS helps to facilitate the role of the OS in the phototransduction
pathway by synthesizing the proteins needed in the OS, as well trafficking these protein to their
desired locations within the OS (4).

(Figure 3) Cone Triad, Kolb, 2013

(Figure 4) Rod Triad, Kolb, 2013
b. RP Symptoms Overview
The initial stages that accompany RP are noted by the loss of rod cells within the retina.
The first symptom of RP is the occurrence of night blindness due to the loss of the rod
photoreceptors, as well as a slow and progressive loss in the visual field (NEI, 2015). Another
symptom of RP is photophobia; a condition where bright lights begin to become uncomfortable,
and later unbearable to those suffering with the disease. There are a plethora of gene mutations
which lead to RP, and thus the prognosis of RP is not the same for each patient. In extreme cases
these symptoms progress to blindness, as most of the cones and rods have undergone apoptosis.
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While in other cases the disease is nonsyndromic, and thus patients find themselves living an
unafflicted lifestyle in terms of other parts of their body being affected by RP (5).
Phototransduction is the process of converting light into electrical signals through the
photoreceptor cells. Before light makes any initial contact with the back of the retina the
photoreceptor cells – unlike other cells of the body – are initially depolarized. This constant
depolarization causes an increased concentration of inhibitory neurotransmitters to be secreted
by the photoreceptor synapses that prevent bipolar cells from depolarizing. When light reaches
the photoreceptors – located in the back of the retina (Figure 5) – the photoreceptors become
hyperpolarized, closing of ion channels occur, and a decrease in the release of neurotransmitters
occurs as long as light is being shown to the photoreceptors (6). This process is disrupted in
individuals with RHO gene mutation and is an important indicator for how such mutations play a
factor in symptoms related to RP.

(Figure 5) Heiting

RP, as mentioned, has a multitude of pathways which lead to cell apoptosis; as well as unique
symptoms that are caused by each genetic mutation. Due to the diverse nature of the genetic
impact of Retinitis Pigmentosa, many researchers have dedicated time to studying the genes
recently identified in non-syndromic RP. While there are currently 80 genetic mutations
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associated with non-syndromic RP (5) – the first to be reported by Dryja et al. being the RHO
gene – many causes, as well as pathologies are still unknown for each of the 80 gene mutations
(Figure 6). For this reason, only a handful of genetic mutations of RP, in particular the RHO
gene mutation, will be reviewed to understand how RP develops in those afflicted by the disease,
as well as understand the few known pathologies of RP.

Disease Progress and Pathologies of Rod and Cone Disorder

(Figure 6) Xu et., al, 2014
RP is a genetically inherited disease which can be inherited by all three means of genetic
inheritance (Figure 6; which addresses the genes most prevalent in each form of the genetically
inherited RP): autosomal dominant, autosomal recessive as well as X-linked pathways of
inheritance. There are 84 known gene mutations that researchers have determined to be linked
with RP, and their affects are unique to each gene mutation (Figure 6). While there are still a
plethora of unknown gene mutations that are attributed to RP (50%) (7), we will seek to discuss
the three genes most commonly associated with the three patterns of inheritance (adRP, arRP,
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xlRP), beginning first with the discussion of the most common type of genetic mutation in adRP
patients; the RHO gene mutation.
a. RHO Gene Malfunction:
One of the first gene mutations discovered by researchers when looking into RP was the
RHO gene mutation. This is the most prevalent mutation among patients suffering from nonsyndromic RP and is an autosomal dominant (adRP) form of the disease. The RHO gene
generates a protein, rhodopsin, which is a key molecule for the visual cycle in rods. Light – in
the form of a photon – is absorbed by the outer segment of the photoreceptors where it then binds
to the visual pigment known as opsin, thus activating rhodopsin (Figure 7) (8). This process is
then immediately proceeded by a transduction cascade in which cGMP-gated channels close (due
to the phosphodiesterase enzyme converting cGMP to GMP) (1). The lower concentration of
cGMP results in Ca2+/Na+ channel closure and hyperpolarization of the photoreceptor (2). All
these steps lead to a decrease in neurotransmitter release from the synapse of the photoreceptor,
depolarizing ON bipolar and ganglion cells and hyperpolarizing OFF bipolar ganglion cells as
well as horizontal cells. This is the beginning of the visual signaling pathway to the thalamus
(lateral geniculate nucleus) and the visual cortex.
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(Figure 7) Dias et, al., 2018

There are six types of mutations that are caused by improper RHO gene behavior and
they are: Class I: correct folding of rhodopsin, but the protein fails to be carried properly to the
outer segment of the photoreceptor, Class II: Improperly folded rhodopsin that is retained in the
ER, Class III: affects process of endocytosis, Class IV: affects post-translation process, Class V:
activation of transducin is increased, and lastly Class VI: properly folded rhodopsin but the opsin
is activated in the absence of the chromophore (1). One important feature that all of these
mutations cause is the increase in stress in the endoplasmic reticulum (ER) of the eye. The ER
has many functions such as protein folding and biosynthesis, but once when a protein – in this
case rhodopsin – is misfolded/unfolded it will be retained in the ER, thus producing organelle

Retinitis Pigmentosa – a Review

Harris 10

stress (1). Once the ER is under stress the human body begins to activate the unfolded protein
response (UPR) mechanism which helps to alleviate this stress . Due to the continuous build-up
of improperly folded proteins in the ER researchers begin to observe the activation of proapoptotic pathways (1). This leads many researchers to question what other genes also cause the
increase in these apoptotic pathways.
b. RPGR Mutation (xlRP)
RPGR gene mutation is the next most common genetic mutation found in patients
diagnosed with RP (making up 4% of all cases in X-linked inheritance) (7). RPGR functions by
instructing the synthesis of protein that are essential for normal vision in the eye. Although the
protein that RPGR codes for is not well understood, the proteins main role suggests that it is
important for maintaining cilia structures of the photoreceptors OS. The segment of the RPGR
gene most noted to affect the retina is the isoform ORF15 exon, which is thought to maintain the
photoreceptors by regulating the function of the cilia. A study of 22 males with X-linked RP
found the presence of an atrophic ring developing around the fovea of one of the patients.
Researchers noted that the progression of the disease with the RPGR mutations was similar to
age-related macular degeneration in autopsy eyes; which initially showed structural changes in
the parafoveal zone (containing both rods and cones), while sparing the central foveal
(exclusively cones) (9). The implication of this discovery was that rods, rather than cones, were
initially affected by the pathway of the disease (9). While rods were the most notably affected
photoreceptors in patients with RPGR-OFR15 protein mutation, the function of the cone
photoreceptors were also affected (10).
c. USH2A Gene Mutation (arRP)
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USH2A (Usherin) gene mutation affects 9% of all known autosomal dominant (adRP)
patients in the world (7). The USH2A gene is most common in patients suffering from the Usher
syndromic form of RP which affects both hearing and visual sensations in patients (11). USH2A
genes primary function is the long-term maintenance of the retinal photoreceptors, as well as the
development of the cochlear hair cells. Mutation of this gene leads to photoreceptor
degeneration and a moderate hearing impairment most noted in patients with Usher syndrome.
(11). In a study comparing wild type (WT) mice with USH2A(-/-) – down-regulated USH2A
gene) – mice researchers found that just before 10 months of age both WT and USH2A(-/-)
retinal functions were unaffected. Once reaching 10 months of age differences in photoreceptor
morphology (i.e. nuclear layer thickness, inner and outer segment length) was beginning to
appear in the USH2A(-/-) mice, as well as an up-regulation of glial fibrillary acidic protein
(GFAP) after mice became 10 months of age (11). This up-regulation in GFAP is a nonspecific
indicator of degeneration in the photoreceptor cells and is most noted before the loss of the entire
photoreceptor takes place. As the mice began to age further degeneration of the photoreceptors
began to take shape through the shortening of the IS/OS, and thinning of the photoreceptor
nuclear layer (11). By 20 months of age more than 50% of the photoreceptor cells were lost
entirely (11). While the most affected photoreceptors were the rods, cone cell opsin had
ectopically located to cell bodies due to the severe shortening of the cone OS (11).
When these mutations are present in patients, they lead to devastating effects on the
photoreceptor cells in their untimely demise. One common trait that is repetitive in these genetic
mutations is the loss of rods initially (due to the gene mutations mainly impacting rods),
followed by the loss of cone cells. But why do mutations that seem to be solely expressed in rod
photoreceptors cause death in both cone and rod cells as the disease progresses? Although the

Retinitis Pigmentosa – a Review

Harris 12

mutations discussed have led to many doors opening in understanding the prognosis of the
disease, researchers have proposed three theories that provide greater explanations into
photoreceptor apoptosis, (with the loss of rods occurring first, followed by the loss of cones
thereafter), and loss of visual function in patients.

Cellular mechanism of the disease
a. Reduction of Trophic Support From Rods:
One of the first prevailing theories that researchers believed increased photoreceptor
apoptosis was the trophic stress theory – which was theorized by studying the Nxnl1 gene
mentioned in Progress in Retinal and Eye Research. This gene sequence, most abundant in rods,
produces two proteins; RdCVF-S & RdCVF-L, which act to promote the survival of cones.
What was hypothesized by researchers looking into this gene is that if the Nxnl1 gene is
downregulated in mice with RP there should be a dramatic increase in cone cell death.
Unfortunately, those numbers are not reflective of the hypothesis, seeing that mice who lacked
this gene only saw a 17% reduction in cone cell density (1). What researchers instead found
when downregulating the Nxnl1 gene is that cones became more susceptible to oxidative stress –
namely hyperoxia – as well as metabolic stress due to the lack of glucose being taken up by the
cone photoreceptors (12).
b. Metabolic Stresses:
This then led to the discussion of glucose intake and how it relates to the overall
hypothesis of RP being exacerbated by increase oxygen levels in the retinal tissue (oxidative
stress). One way this was analyzed was through the upregulation of approximately 230 genes at
the time of cone degeneration. What was seen was that of those 230 genes that were found to
have been upregulated, there were approximately 1/3 of those genes that were involved in
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cellular metabolism (12). The greatest of the 1/3 of these upregulated genes that expressed
regulatory control of cellular metabolism were insulin/mTOR pathways. When this pathway was
activated it led to glucose uptake and promoted cone survival (12). When the pathway was
deactivated, researchers found that there was a decrease in glucose uptake, as well as an increase
in oxidative stress in the ER (12). What researchers concluded given these findings was that
with certain aspects of cellular metabolism being disrupted they saw a decrease in cones
throughout the retina, thus alluding to the importance of such pathways – supporting the
metabolic theory of photoreceptor apoptosis when lacking the insulin/mTOR pathways. But what
still remained was the question of why cone cell apoptosis increased only after rod cells undergo
apoptosis? One of the many theories provided by researchers thus far is that oxidative stress is
the main component that leads to significant degeneration of cone photoreceptor cells, once rod
photoreceptor cells have undergone apoptosis. This theory arose from the two previously stated
theories given the trend of increased oxidative stress following researchers’ investigations.
c. Oxidative Stress:
Oxidative Stress is the movement of free radicals within the body that are unbound and
are thus extremely dangerous due to their high reactivity (2). Many of these free radicals tend to
be oxygen in most cases due to the fact that it is the final electron acceptor in the electron
transport chain (12). If free roaming oxygen is present it will tend to bind to upstream electron
donors forming what is known as a superoxide (12). A way that the body combats these
superoxide’s is by activating the antioxidant defense system (ADS), which is activated when
oxygen levels increase. If there are too many free radicals present the ADS might not be able to
handle the high concentration, thus allowing free radicals to roam freely, affecting the bodies
regular functions.
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What lead researchers to first propose this theory of oxidative damage leading to cone
cell apoptosis was initially discovered by accident when researchers were studying whether high
oxygen levels caused low vascular endothelial growth factor (VEGF) levels, and if these
conditions led to regression of the deep capillary bed (12). VEGFs main function is blood vessel
proliferation in the outer retina (13). While researchers were able to examine how VEGF would
behave in high oxygen conditions, they also stumbled upon the realization that photoreceptors
began to undergo degeneration in these conditions as well. The area most affected by the
hyperoxia conditions – where most of the photoreceptor death was reported – was the central
retina; the area of highest choroidal blood flow and highest oxygen delivery (12).
Although the cellular mechanism of blood flow delivery is not directly impacted by RP
the mystery of how cone cells are directly impacted by RP after rod photoreceptors had
undergone apoptosis was a key factor in understanding the spread of the disease in patients, as
well as the slow loss of the central visual field. To help further aid in the discussion of how blood
is carried to the eye to provide nutrients, as well as how the flow of blood furthers cone cell
degeneration after the loss of rod photoreceptors Figures 8 and 9 have been provided below.

(Figure 8) Dr. Amer A Shamsulddin, 2015
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(Figure 9) Coorey et. al., 2012 (14)
If blood vessels were located in front of the photoreceptor cells we would see a decrease
in vision due to the pigmented cells that are carried in the blood vessels. For this reason, a two
part blood supply had evolved to bypass this issue: with the choroidal circulation supplying
oxygen and nutrients to the outer retina, and the retinal circulation supplying the inner (12). As
noted above in Figure 8, the central retinal artery first enters through the optic nerve, which then
sends branching vessels along the surface of the retina to later form the superficial, intermediate
and deep capillary beds that supply the inner retina (figure 9) (12). The ciliary arteries then enter
the posterior portion of the choroid where they branch into the choriocapillaris, allowing a pool
of plasma to form along the RPE. This plasma pool contains a high concentration of oxygen,
allowing for a steep concentration gradient to occur which pushes the diffusion of oxygen into
the outer retina (12). When oxygen levels were high in the inner retina, this would result in a
process called autoregulation: which causes retinal blood vessels to constrict, reducing both
blood flow to that area as well as oxygen. Since choroidal vessels do not enter into the outer
segment of the retina there is no such adjustment if there is an increase in oxygen taking place in
the outer retina segment. It was originally hypothesized that rod cell apoptosis would lead to
higher levels of oxygen in the retina because rods constitute approximately 95% of the cells in
the outer nuclear layer (ONL), as well as the fact that they contain an abundance of mitochondria
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within them, thus their elimination would lead to a reduction in oxygen consumption in the outer
retina and more free radicals would be allowed to roam. Researchers found that in mouse models
there was an increased spillover of oxygen from the outer retina to the inner retina following rod
cell apoptosis. Further tracking of these mouse models showed that after 20 days, prior to rod
degeneration, there was a reduction in oxygen at the outer border of the ONL in the region of the
photoreceptor IS (12). These higher levels of oxygen being unable to be used by the rods – as
well as being unable to be taken out from the outer segment due to the lack of autoregulation –
would then cause further rod cell degeneration as mouse models began to further develop. After
complete rod degeneration had taken place, cone cells were then susceptible to a four times
greater oxygen concentration in the outer retina, and the IS of the cones were shown to have
severe oxidative damage (12). These findings lead researchers to believe that in patients with RP
cones cells began to undergo apoptosis strictly after a majority of rod photoreceptors underwent
apoptosis due to the recorded higher levels of oxygen left after rod cell death occurred. Given
that rods are the most abundant photoreceptors in the eye (around 110,000,000 to 125,000,000)
when compared to cones (6,400,000) (3), it came as no surprise as to how impactful the increase
in oxygen supply would be once the majority of photoreceptors had undergone apoptosis.

Symptoms in Early and Late Phases of the Disease
Given the fact that RP has varying genetic modes of inheritance as discussed prior, the
progress of symptoms within patients varies from a case by case basis. Although there are
syndromic forms of RP that are present in some forms of the disease (i.e. Ushers Syndrome) they
all tend to follow a particular onset of symptoms in early stages that lead to the disease
progression into later stages.
a. Early Stages
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The earliest symptoms associated with RP patients is the loss of night vision (night
blindness). This symptom is associated with all cases of RP, with the main differences being the
progression of the night blindness either taking shape early in life (infanthood) or taking place
during the second decades of life (adolescents) (15). The occurrence of night blindness tends to
be overlooked in the teenage years since normal day light functioning defects either do not exist
or are so minimal that patients tend to carry out normal everyday functions with ease. Visual
acuity – used by many in the medical field to determine if any visual field impairments are
present – tends to be normal or subnormal in patients during the early onset of the disease, thus
making it extremely difficult to provide a diagnosis as early as possible (15). Fundus
examinations in patients with early onset of the disease show no indication of bone spiculeshaped pigment deposits, and the attenuation of the retinal arterioles are intact with normal optic
discs present in most cases (15).
b. Mid Stages
In mid stages of the disease progression it becomes clear to the patients that they have severe
loss of night vision, with difficulty driving in unknown places, walking in dimly lit areas, and
performance of tasks without assistance in the dark is near impossible (15). The progressive loss
of the periphery field of vision becomes apparent during normal day light conditions at this
stage, with patients unable to see pedestrians or cars to their side, as well a decrease in hand-eyecoordinated tasks such as handshakes. While patients have been known to cope with these
symptoms with the use of family members to help them drive at night, normal daily life
functions begin to steadily decrease overtime (15). Photophobia (especially in the presence of
diffuse light) is the next symptom that develops during this stage. This leads to difficulty in tasks
such as reading since there is a narrow window of acceptable light conditions individuals can
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bear to be in (15). A decrease in visual acuity is noted with the presence of subcortical posterior
cataracts, and fundus images reveal the presence of bone spicule-shaped pigment deposits within
the midperiphery, as well as atrophy beginning to take place within the retina (15).
c. Late/End Stage
The late/end stages of RP are marked by the inability of patients to move on their own without
assistance due to severe loss of periphery vision (classical tunnel vision), with few degrees of
visual field remaining around a particular fixation point (15). Reading becomes all but
impossible without the usage of magnifying glasses, and there is marked increase in photophobia
in the patient with difficulty handling any form of light, no matter the intenseness (15). Fundus
examinations reveal widespread pigment deposits reaching the macular region of the eye.
Vessels become extremely thin, and the optic disk has a waxy pallor (15). Although RP may
progress to complete blindness in patients the ability to perceive light in the periphery visual
field may still remain (15).

Current Treatments of RP
a. Antioxidants
Given the findings of the oxidative stress theory, many researchers looked into how
antioxidants would fair in patients with RP. In one study researchers used a mixture of
antioxidants such as alpha-tocopherol, ascorbic acid, MnTBAP as well as alpha-lipoic acid to
test the effects on two sets of mice models: rd1/rd1 (rapidly progressing RP) mice and rd10/rd10
(slow progressive recessive RP) mice. In the rd1/rd1 mice when the mixture was given
researchers saw that cone cell death was reduced in this model of RP (16), but still progressed
overtime. In the rd10/rd10 mice, given that photoreceptors took a longer time to degenerate, once
antioxidants were given researchers found significantly greater cone survival, increased cone
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function in photopic ERG b-wave amplitudes, prolonged rod survival, and lastly slowed
depletion of rhodopsin mRNA (16). What these findings indicate is that not only can
antioxidants be used to promote cone cell survival, but that if given early in RP mice models they
can benefit both photoreceptors as a whole, as well as slow the onset of disease symptoms (16).
Additionally, in rd10/rd10 mice models given this antioxidant mixture, it points to the fact that
oxidative stress not only damages cone cells directly, but that rod cells are also affected by the
increase in oxygen concentration once the disease begins to progress. While this study was not
completed on human subjects it opens the field to future studies being taken on patients suffering
with RP to see if the same affects can be demonstrated.
b. Subretinal Adipose Tissue-derived mesenchymal stem cell implantation
Researchers believed that stem cells, in particular mesenchymal stem cells (MSC’s), had
the ability of performing multiple functions for the eye such as immunoregulation, stopping
photoreceptor cell apoptosis, as well as neurotrophin secretion (17). The use of embryonic stem
cells has been used in many forms of surgical procedures, but researchers wished to test if it
would have any significant effect on reversing the effects of RP on patients with end stage RP
(those with 20/2000 vision) (17). With experimental studies reporting that MSCs had the
potential to differentiate into progenitor cells in the retina, and retinal neural-like cells, this
clinical trial was important to further understand whether RP could be reversed at later stages of
the disease. If any progress was to be reported during the experiment ran, it would lead
researchers to further usage of stem cells when it pertains to irreversible retinal diseases, such as
RP.
The promise of using MSC’s to differentiate into other cells – in particular the
photoreceptor cells of RP patients – was increasingly pertinent into further research using stem
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cells in other fields. MSC’s provide further capability of modulating the plasticity of the damage
host cells they are planning on targeting (17). Furthermore, these particular cells are able to
secrete neurotrophic and survival-promoting growth factors (which will discussed in detail in
nerve growth factor eye drops), restore synaptic networks, as well as re-establish functional
connections in areas otherwise lost(17). The conclusion of the study, although extremely
promising, did not yield as many positive results as was expected. While the implantation of the
stem cells into the eye was successful, there is no routine delivery technique that is in use today
to ensure that all test subjects were given the correct amount of stem cells. Also, out of all the
patients that were seen, only one patient experienced some type of visual acuity improvement
from 20/2000 vision to 20/400. While this is a huge leap from where the patient was initially
reported to have been pre-stem cell implantation, they are still considered legally blind – as were
all the other patients – and the procedure did not present any long lasting results (17). What has
been suggested to ensure that the results are better tailored to more patients is providing a more
efficient delivery method, as well as a larger study sample with less deterioration in the visual
field to see if the results will vary with people who have extreme RP degeneration (late stage)
compared to patients with acute RP degeneration. This study did not account for syndromic
forms of RP.
c. Nerve Growth Factor (NGF) Eye drops
In a clinical study conducted by Falsini et al,. researchers wished to study the effects of
Nerve Growth Factor (NGF) eye drop treatment on patients with RP. As previously stated, there
is no current cure for RP, but what is known of RP is that photoreceptor apoptosis is the last and
final outcome of the disease. Researchers believed that NGF eye-drops had a promising future
given the fact that neurotrophic factors are associated with the ability to inhibit apoptotic cascade
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pathways within the body (18). The usage of neurotrophic factors was first utilized in a study
conducted by the Royal College of surgeons, where they were able to see a decrease in the
degeneration of photoreceptor cells in rats with RP, when injections of basic fibroblast growth
factor (bFGF) was utilized (18).
NGF’s seemed like a promising venture for the researchers due to its ability to promote
photoreceptor survival in animal models with RP. What was interesting to note, however, was
that there was a negative effect that these neurotrophic factors may possibly display. While the
NGF may provide photoreceptor neuroprotection, the price that may have been paid would have
been the decrease in retinal sensitivity (18). While you would still be able to retain some
photoreceptors, in the long run the researchers would have to ask whether the potential risks
were worth the cost. While obviously not life threatening, the question of whether this posed a
threat to the patients in the long term still remained an issue that researchers had to ask.
The clinical trial continued by running routine eye exams on 8 patients who had a history
of progressive RP. The results concluded that none of the patients suffered any adverse reactions
to the NGF eye drops, as well as no adverse changes to the retina (which were one of the fears of
the researchers) (18). Three patients out of the eight reported subjective improvement with their
vision which was confirmed by the Goldmann visual field – a test that uses markers to indicate
where there is loss in a person’s field of vision, or, in this case, a possible gain in a patients
visual field. This particular data indicates that NGF administration may possibly improve retinal
function, but not among a broad spectrum of RP patients. This study did not account for
syndromic forms of RP.
The exact mechanism of how NGF’s effect photoreceptors is not known, although
researchers have hypothesized that inside the mammalian retina NGF receptors are expressed
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within the Müller and retinal ganglion cells (RGC), but are not directly located on the outer
nuclear layer (ONL) indicating that NGF’s play an indirect role in their neuroprotective abilities
of photoreceptors (18). While nothing is conclusive on the direction of this study, it will still be
important to see whether researchers can still capitalize on the usage of NGF eye drops, or other
forms of neuroprotective substances.

Conclusion
Retinitis Pigmentosa is a disease which affects around 2.5 million people worldwide (1 out of
every 4000 affected). This review looked to observe how the disease progresses, as well as how
the different modes of inheritance – autosomal dominant, autosomal recessive and X-linked –
targets photoreceptors through their own unique mutations. Due to these varying genetic
mutations discussed within the review; such as the RPGR, USH2A and RHO mutations,
researchers do not know of an exact pathology that can be attributed to the disease seeing as each
genetic form of RP brings up a new genetic pathway researchers must analyze in order to better
asses possible treatments. The metabolic, trophic and oxidative theories discussed throughout
this review looked to connect the diseases’ prognosis to make it easier to find a cure, but, due to
the varying genetic mutations of RP a “all-for-one” treatment seems to be out of reach for the
time being. Although many of the potential treatments posed within this review seemed to show
some indication of bettering visual acuity within patients suffering with RP, the disease was not
hindered from affecting many of the patients’ central field of vision, as well as showing no visual
field improvement in patients who had almost complete loss of both central and periphery visual
field vision.
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